Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide

Klinische Padiatrie

Volumn 218, Issue 3, 2006, Pages 180-184

  Ehlert, Karoline ^a   Groll, A H ^a   Kuehn, J ^a   Vormoor, J ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Bone marrow transplantation; Cytomegalovirus; Leukaemia; Refractory viral infections

Indexed keywords

ACICLOVIR; CIDOFOVIR; CYTOMEGALOVIRUS ANTIGEN PP65; FOSCARNET; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE;

ANAMNESIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD DONOR; CASE REPORT; CYTOMEGALOVIRUS INFECTION; GRAFT FAILURE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; LEUKOPENIA; LIVER TOXICITY; MALE; MONOTHERAPY; NEPHROTOXICITY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; RECURRENT DISEASE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT FAILURE;

ANTIVIRAL AGENTS; BONE MARROW PURGING; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; FOSCARNET; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; INFANT; ISOXAZOLES; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MALE; OPPORTUNISTIC INFECTIONS; RETREATMENT;

EID: 33744497073     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-933412     Document Type: Article

References (12)

1. Ljungman P. Prevention and treatment of viral infections in stem cell transplant recipients. British Journal of Hematology 2002; 118: 44-57
2. Boeckh M. Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy. Transplantation Infectious Diseases 1999; 1: 165-178
3. Waldman WJ, Knight DA, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation 1999; 68: 814-825
4. Williams JW, Mital D, Chong A, Kottayil A, Millis M, Longstreth J, Huang W, Brady L, Jensik S. Experiences with leflunomide in solid organ transplantation. Transplantation 2002; 73: 358-366
5. Chong AS, Huang W, Liu W, Luo J, Shen J, Xu W, LianLi M, Blinder L, Xiao F, Xu X, Clardy C, Foster P, Williams JA. In vivo activity of leflunomide: Pharmacokinetic analyses and mechanism of immunosuppression. Transplantation 1999; 68: 100-109
6. Cutolo M, Sulli A, Ghiorzo P, Pizzorni C, Craviotto C, Villaggio B. Antiinflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2003; 62: 297-302
7. Silverman E, Mouy R, Spiegel L, Jung LK, Saurenmann RK, Lahdenne P, Horneff G, Calvo I, Szer IS, Simpson K, Stewait JA, Strand V, Leflunomide in Juvenile Rheumatoid Arthritis (JRA) Investigator Group. Leflunomide or methotrexate for juvenile rheumatoid arthritis. New England Journal of Medicine 2005; 37: 1655-1666
8. Waldman WJ, Knight DA, Blinder L, Shen J, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology 1999; 42: 412-418
9. Avery RK, Bolwell BJ, Yen-Lieberman B, Lurain N, Waldman WJ, Longworth DL, Taege AJ, Mossad SB, Kohn D, Long JR, Curtis J, Kalaycio M, Pohlman B, Williams JW. Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection. Bone Marrow Transplantation 2004; 34: 1071-1075
10. John GT, Mantivannan J, Chandy S, Peter S, Fleming SJ, Balakrishnan N, Krishnamurthy K, Kirubakaran MG, Jacob CK. A Prospective Evaluation of Leflunomide Therapy for Cytomegalovirus Disease in Renal Transplant Recipients. Transplantation Proceedings 2005; 37: 4303-4305
11. Schuster FR, Simon A, Laws HJ, Beutel K, Groll AH, Jäger G, Schuster V. Diagnose und Therapie von Virusinfektionen bei Kindern und Jugendlichen mit neoplastischen Erkrankungen. Klinische Pädiatrie 2005; 217 (Suppl 1): S67-S84
12. Sokos DR, Berger M, Lazarus HM. Intravenous Immunoglobulin: Appropriate Indications and Uses in Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2002; 8: 117-130